This afternoon we watched Tenet Healthcare drop -10.0% to a price of $124.91 per share. The Large-Cap Medical Care Facility company is now trading -29.17% below its average target price of $176.36. Analysts have set target prices ranging from $140.0 to $217.0 per share for Tenet Healthcare, and have given the stock an average rating of buy.
The stock has an average amount of shares sold short at 4.1%, and a short ratio of 2.94. The company's insiders own 1.57% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 101.7% of Tenet Healthcare's shares being owned by this investor type.
Institutions Invested in Tenet Healthcare
Date Reported | Holder | Percentage | Shares | Value |
---|---|---|---|---|
2024-12-31 | Blackrock Inc. | 11% | 10,552,615 | $1,318,127,178 |
2024-12-31 | Vanguard Group Inc | 11% | 10,074,795 | $1,258,442,680 |
2024-09-30 | FMR, LLC | 8% | 7,700,693 | $961,893,590 |
2024-09-30 | Price (T.Rowe) Associates Inc | 8% | 7,468,372 | $932,874,373 |
2024-09-30 | Invesco Ltd. | 5% | 5,042,292 | $629,832,712 |
2024-12-31 | Pacer Advisors, Inc. | 4% | 3,832,530 | $478,721,336 |
2024-09-30 | State Street Corporation | 3% | 2,907,644 | $363,193,822 |
2024-09-30 | Glenview Capital Management, Llc | 3% | 2,658,791 | $332,109,593 |
2024-09-30 | Geode Capital Management, LLC | 2% | 2,044,667 | $255,399,362 |
2024-09-30 | Arrowstreet Capital, Limited Partnership | 2% | 1,815,484 | $226,772,113 |
Besides an analyst consensus of strong upside potential, other market factors point to there being positive market sentiment on Tenet Healthcare.